Molecules in blood may predict cancer risk
Prostate cancer is the fourth most common cancer, with around 1.3m cases diagnosed in 2018. A new study, part-funded by WCRF and published in the International Journal of Cancer, suggests molecules in the blood, known as metabolites, may be able to predict aggressive prostate cancer risk.
Read the results and conclusions of this study »
|